Lapatinib and Doxorubicin Hydrochloride Liposome in Treating Patients With Metastatic Breast Cancer

NCT00316875 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: lapatinib ditosylate
DRUG: Doxil

Sponsor

Northwestern University

Collaborators

[object Object]